Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT06373354
- Status
- Recruiting
Conditions
- Architectural Distortions
- Breast Tomosynthesis
Eligibility Criteria
- Sex
- FEMALE
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Digital Breast Tomosynthesis (DBT) — DEVICEUndergo tomosynthesis imaging
Study Details
To compare narrow-angle digital breast tomosynthesis (DBT) and wide-angle DBT.
Key Dates
- Start date
- Oct 18, 2024
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Digital Breast Tomosynthesis (DBT)Participants that agree to take part in this study, your standard follow-up imaging will be done using an FDA approved DBT system, but it will be different from the DBT system used for your routine screening. For example, if narrow-angle DBT was used for your routine screening, then you will have standard wide-angle DBT. If wide-angle DBT used for your routine screening, then you will have narrow-angle DBT. These images will be used for diagnosis and to help decide your further care.
Primary Outcome Measure
Safety and adverse events (AEs) [ Time Frame: Through study completion; an average of 1 year ]
Central Contacts
- Beatriz Adrada, MD(713) 792-2709
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MD Anderson Cancer Center | Houston | Texas | 77030 | Beatriz Adrada, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site